RNF43
RNF43 (ring finger protein 43) is a RING-type E3 ubiquitin-protein ligase that acts as a negative regulator of Wnt signalling by promoting turnover of Frizzled receptors. It is also known as RNF124, URCC, FLJ20315 and DKFZp781H0392. Browse Assay Genie's current range of RNF43 research reagents below, or read on for the biology behind the target.
RNF43 is an E3 ubiquitin-protein ligase that negatively regulates the Wnt signalling pathway. It mediates the ubiquitination, endocytosis and subsequent degradation of Frizzled, the Wnt receptor complex components. Expression of the RNF43 gene increases ubiquitination of Frizzled receptors and alters their subcellular distribution, which reduces the level of these receptors at the cell surface. RNF43 acts on both canonical and non-canonical Wnt signalling. Together with RSPO2 and ZNRF3, it forms a master switch that governs limb specification.
The RNF43 protein is predicted to contain a transmembrane domain, a protease-associated domain, an ectodomain and a cytoplasmic RING domain, the catalytic module typical of RING-type E3 ligases. UniProt places it at the cell membrane, the endoplasmic reticulum membrane and the nuclear envelope. It belongs to the ZNRF3 family and, in HGNC classification, to the ring finger proteins and the RING finger E3 ubiquitin protein ligases. Alternative splicing of the human gene gives rise to multiple transcript variants encoding different isoforms, and the mouse ortholog is Rnf43.
Mutations in RNF43 have been reported in multiple tumour cells, including colorectal and endometrial cancers, which makes the protein a point of interest for studies of Wnt-driven disease. The gene has also been catalogued under the aliases RNF124 and URCC, as well as the clone-derived names FLJ20315 and DKFZp781H0392.
RNF43 negatively regulates canonical and non-canonical Wnt signalling by driving ubiquitination and degradation of Frizzled receptors.
As a RING-type E3 ligase, RNF43 is a model for studying ubiquitination-dependent endocytosis and degradation of cell-surface receptors.
Mutations in RNF43 have been reported in multiple tumour cells, including colorectal and endometrial cancers.
Together with RSPO2 and ZNRF3, RNF43 forms a master switch that governs limb specification.
RNF43 is an E3 ubiquitin-protein ligase that negatively regulates Wnt signalling. It ubiquitinates Frizzled receptors, promoting their endocytosis and degradation, so that fewer receptors remain at the cell surface. It acts on both canonical and non-canonical Wnt pathways.
RNF43 (ring finger protein 43) is also called RNF124, URCC, FLJ20315 and DKFZp781H0392. UniProt names it E3 ubiquitin-protein ligase RNF43. Alternative splicing produces multiple transcript variants that encode different isoforms.
Mutations in the RNF43 gene have been reported in multiple tumour cells, including colorectal and endometrial cancers. A mouse ortholog, Rnf43, exists, and the protein belongs to the ZNRF3 family. Check the datasheet of any product for its validated reactivity.
Other RING finger E3 ubiquitin ligases from the same gene group, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q68DV7; product specifications from Assay Genie datasheets.